Folgen
Gerhard Walzl
Gerhard Walzl
Bestätigte E-Mail-Adresse bei sun.ac.za - Startseite
Titel
Zitiert von
Zitiert von
Jahr
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
DE Zak, A Penn-Nicholson, TJ Scriba, E Thompson, S Suliman, LM Amon, ...
The Lancet 387 (10035), 2312-2322, 2016
7442016
Immunological biomarkers of tuberculosis
G Walzl, K Ronacher, W Hanekom, TJ Scriba, A Zumla
Nature Reviews Immunology 11 (5), 343-354, 2011
6372011
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla
The lancet 375 (9729), 1920-1937, 2010
6242010
Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response
TJ Scriba, B Kalsdorf, DA Abrahams, F Isaacs, J Hofmeister, G Black, ...
The Journal of Immunology 180 (3), 1962-1970, 2008
5402008
Diagnostic tools in tuberculous pleurisy: a direct comparative study
AH Diacon, BW Van de Wal, C Wyser, JP Smedema, J Bezuidenhout, ...
European Respiratory Journal 22 (4), 589-591, 2003
5312003
Genital inflammation and the risk of HIV acquisition in women
L Masson, JAS Passmore, LJ Liebenberg, L Werner, C Baxter, KB Arnold, ...
Clinical Infectious Diseases 61 (2), 260-269, 2015
4302015
Human gene expression profiles of susceptibility and resistance in tuberculosis
J Maertzdorf, D Repsilber, SK Parida, K Stanley, T Roberts, G Black, ...
Genes & Immunity 12 (1), 15-22, 2011
3652011
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
S Tiberi, N du Plessis, G Walzl, MJ Vjecha, M Rao, F Ntoumi, S Mfinanga, ...
The Lancet Infectious Diseases 18 (7), e183-e198, 2018
3642018
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
G Walzl, R McNerney, N du Plessis, M Bates, TD McHugh, NN Chegou, ...
The Lancet Infectious Diseases 18 (7), e199-e210, 2018
3072018
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
ST Malherbe, S Shenai, K Ronacher, AG Loxton, G Dolganov, M Kriel, ...
Nature medicine 22 (10), 1094-1100, 2016
2732016
Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response
JM Cliff, JS Lee, N Constantinou, JE Cho, TG Clark, K Ronacher, EC King, ...
The Journal of infectious diseases 207 (1), 18-29, 2013
2682013
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ...
Aids 24 (6), 819-831, 2010
2672010
Four-gene pan-African blood signature predicts progression to tuberculosis
S Suliman, EG Thompson, J Sutherland, J Weiner 3rd, MOC Ota, ...
American journal of respiratory and critical care medicine 197 (9), 1198-1208, 2018
2552018
Biomarkers of inflammation, immunosuppression and stress are revealed by metabolomic profiling of tuberculosis patients
J Weiner 3rd, SK Parida, J Maertzdorf, GF Black, D Repsilber, A Telaar, ...
PloS one 7 (7), e40221, 2012
2422012
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa
K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ...
The Journal of infectious diseases 206 (1), 6-14, 2012
2422012
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes
R Roy Chowdhury, F Vallania, Q Yang, CJ Lopez Angel, F Darboe, ...
Nature 560 (7720), 644-648, 2018
2392018
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report
NN Chegou, GF Black, M Kidd, PD Van Helden, G Walzl
BMC pulmonary medicine 9, 1-12, 2009
2152009
Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection
GR Stewart, VA Snewin, G Walzl, T Hussell, P Tormay, P O'Gaora, ...
Nature medicine 7 (6), 732-737, 2001
2012001
Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study
L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ...
Sexually transmitted infections 90 (8), 580-587, 2014
1982014
An evaluation of commercial fluorescent bead-based luminex cytokine assays
JF Djoba Siawaya, T Roberts, C Babb, G Black, HJ Golakai, K Stanley, ...
PloS one 3 (7), e2535, 2008
1972008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20